Suchen
Nutriband Inc
NTRBZur Watchlist hinzufügen
3.090USD
-0.100-3.13%
Handelsschluss 07/01, 16:00（ET）Kurse um 15 Minuten verzögert
37.56MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Nutriband Inc Unternehmen
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Nutriband Inc Informationen
BörsenkürzelNTRB
Name des UnternehmensNutriband Inc
IPO-datumJun 20, 2017
CEOMelnik (Serguei)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeJun 20
Addresse121 S Orange Ave Ste 1500
StadtORLANDO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32801-3241
Telefon14073776695
Websitehttps://nutriband.com/
BörsenkürzelNTRB
IPO-datumJun 20, 2017
CEOMelnik (Serguei)
Führungskräfte von Nutriband Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Nutriband Inc?
Die fünf größten Anteilseigner von Nutriband Inc sind: Mr. Serguei Melnik
Wie viele Institutionen halten Anteile an Nutriband Inc (NTRB)?
Mit Stand vom 2026Q1 halten 45 Institutionen Anteile an Nutriband Inc, mit einem Gesamtmarktwert von etwa 579.57K, was 4.77% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 106153.00 gestiegen.